IL188330A0
(en )
2008-04-13
Processes for the preparation of
HRP20150417T1
(en )
2015-09-25
Process for the preparation of opioid modulators
ZA200705425B
(en )
2008-09-25
Method for the manufacture of hydrocarbons
GB0526291D0
(en )
2006-02-01
Therapeutic method
ZA200903533B
(en )
2010-03-31
Process for the preparation of rosuvastatin
EP1893625A4
(en )
2012-12-26
Methods for the preparation of 9-deazapurine derivatives
ZA200804264B
(en )
2009-01-28
Process for the preparation of ferri-succinylcasein
ZA200601910B
(en )
2006-11-29
Process for the preparation of organosilances
GB0910201D0
(en )
2009-07-29
The preparation method of 2-deoxy-l-ribose
IL213474A0
(en )
2011-07-31
Processes for the preparation of cyclopropyl-amide derivatives
EP1964538A4
(en )
2013-04-10
Preparation method of pharmaceutials
PT1937662E
(en )
2009-10-27
Process for the preparation of duloxetine
HUP0500685A2
(en )
2007-07-30
Pharmaceutical composition for the treatment of psychosis
HU0401379D0
(en )
2004-09-28
Process for the preparation of risperidon
PL376031A1
(en )
2007-01-08
Method for the manufacture of highly mineralized medicinal salt
PL376691A1
(en )
2007-03-05
Method for the manufacture of N-phenyl-2-pyrimidine-amine derivatives
PL378004A1
(en )
2007-05-14
Method for the manufacture of R-pantolactone
PL373928A1
(en )
2006-10-02
Method for the manufacture of imatinibe
PL378375A1
(en )
2007-06-25
Method for the manufacture of the BaTi0₃ nanoceramics
SI1732916T1
(en )
2007-10-31
Process for the preparation of alkoxycarbonylmethoxy-cyclopentanes
PL369884A1
(en )
2006-03-06
Method for the manufacture of substituted cyanovinyloxiranes
PL372016A1
(en )
2006-07-10
Method for the manufacture of derivatives of n-phenyl-2-pyrimidinamines
GB0509930D0
(en )
2005-06-22
Therapeutic method
GB0521562D0
(en )
2005-11-30
Therapeutic method
GB0521547D0
(en )
2005-11-30
Therapeutic method